Search

Your search keyword '"Mazzarelli C"' showing total 211 results

Search Constraints

Start Over You searched for: Author "Mazzarelli C" Remove constraint Author: "Mazzarelli C"
211 results on '"Mazzarelli C"'

Search Results

1. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept

2. Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation

3. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

4. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

5. Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study

6. Nationwide survey of liver transplantation for Primary Sclerosing Cholangitis in Italy

8. Survey on hepatic sarcoidosis in Italy

9. Individualized HBIG withdrawal in an historical cohort of liver transplant recipients in Italy

14. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

15. A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients

16. High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

17. Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe

18. Epistolary exchanges, academic training, and social capital: Joseph Anton Koch at the Hohe Karlsschule in Stuttgart

19. Liver transplantation for primary sclerosing cholangitis

20. High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

21. Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

23. Liver transplant recipients with Covid-19: results from an Italian multicenter cohort

24. Liver transplant candidates and SARS-CoV-2 infection: Results from an Italian multicenter cohort

25. Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study

26. Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

27. The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience

28. Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting

29. The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities

31. Sarcopenia in liver transplant candidates

34. Common issues in the management of patients in the waiting list and after liver transplantation

35. AISF position paper on HCV in immunocompromised patients

36. Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy

37. LIVER TRANSPLANTATION IN HIV-POSITIVE PATIENTS: THE INITIAL EXPERIENCE

38. PRE-EMPTIVE POST-TRANSPLANT HCV TREATMENT WITH IFN-FREE DAA: PRELIMINARY RESULTS FROM A PILOT STUDY

39. 03:18 PM Abstract No. 75 Portal cavernoma revascularization through splenic access in symptomatic portal hypertension: a paradigm shift in interventional radiology

40. Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study

41. Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia

42. Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study

43. Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study

44. Prophylaxis of venous thromboembolism in elderly patients with multimorbidity

47. The percentage of patients with HCV infection in need of a liver transplant is rapidly declining while their survival after transplantation is improving: A study based on European liver transplant registry

Catalog

Books, media, physical & digital resources